Oral Protein Fibril Microgels with Gastric Stability and Intestinal Targeting Enhance Capsaicin Bioavailability for Effective Obesity Prevention
Journal of Agricultural and Food Chemistry · 04.11.2026 · 74 (43) · 34067-34082
DOI: 10.1021/acs.jafc.6c12370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 20.10.2026. Verfasst von Hui Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Food Colloids and Delivery of Functionality, College of Food Science and Nutritional Engineering, China Agricultural University, B…. Hauptthemen laut MEDLINE: Capsaicin, Microgels, Obesity, Whey Proteins. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hainan Province, National Key Research and Development Program of China.
Abstract (Originalsprache)
To address the susceptibility of protein fibrils to pepsin degradation, this study proposed a fibril-to-microgel hierarchical assembly strategy, where flexible whey protein isolate fibrils (WPIF) and rigid flaxseed protein isolate fibrils (FPIF) were in situ self-cross-linked into microgels via a W/O emulsion template, followed by capsaicin (Cap) loading. Both microgels exhibited high gastric stability and intestinal response release properties. Compared with WPIF-based microgels (WPIFM), FPIF-based microgels (FPIFM) exhibited a more sustained intestinal digestion profile, leading to a higher Cap bioavailability. In high-fat-diet-induced obese mice, Cap-loaded microgels (WPIFM/Cap and FPIFM/Cap) effectively prevented metabolic disorders, as evidenced by reduced lipid accumulation, hepatic steatosis, and pro-inflammatory cytokines, with FPIFM/Cap demonstrating the highest protective efficacy. Both microgels modulated gut microbiota homeostasis, with FPIFM/Cap uniquely enriching Akkermansia, potentially due to its high arginine content and its stable fibrillar structure. This work provides a proof of concept for upcycling agricultural processing byproduct proteins into high-performance biomaterials for mitigating metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Food Colloids and Delivery of Functionality, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing100083, P. R. China.
- College of Smart Agriculture (Research Institute), Xinjiang University, Urumqi830017, China.
- College of Food Science and Engineering, Tarim University, Aral843300, China.
ORCID-Profile: Xuefeng Yin, Jun Liu, Yansong Xue, Yuan Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hainan Province
- National Key Research and Development Program of China
- Guangdong Provincial Key Laboratory of Nutraceuticals and Functional Foods
Zitieren
APA
Zhang, H., Cui, Y., Wu, K., Yin, X., Liu, X., Liu, J., Xue, Y., Ye, Z., Li, F., Li, X., & Li, Y. (2026). Oral Protein Fibril Microgels with Gastric Stability and Intestinal Targeting Enhance Capsaicin Bioavailability for Effective Obesity Prevention. Journal of Agricultural and Food Chemistry, 74(43), 34067-34082. https://doi.org/10.1021/acs.jafc.6c12370
Vancouver
Zhang H, Cui Y, Wu K, Yin X, Liu X, Liu J, et al. Oral Protein Fibril Microgels with Gastric Stability and Intestinal Targeting Enhance Capsaicin Bioavailability for Effective Obesity Prevention. Journal of Agricultural and Food Chemistry. 2026;74(43):34067-34082. doi:10.1021/acs.jafc.6c12370
BibTeX
@article{Zhang2026,
author = {Zhang, Hui and Cui, Yaru and Wu, Kaiwen and Yin, Xuefeng and Liu, Xiangyu and Liu, Jun and Xue, Yansong and Ye, Ziqin and Li, Fen and Li, Xing and Li, Yuan},
title = {Oral Protein Fibril Microgels with Gastric Stability and Intestinal Targeting Enhance Capsaicin Bioavailability for Effective Obesity Prevention},
journal = {Journal of Agricultural and Food Chemistry},
year = {2026},
volume = {74},
number = {43},
pages = {34067--34082},
doi = {10.1021/acs.jafc.6c12370}
}
EUVIMED